Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2212-7968
  • E-ISSN: 1872-3136

Abstract

Gankyrin, a newly defined oncoprotein also known as PSMD10 and P28, functions as a dual-negative regulator of the two most prominent tumor suppressor pathways, the CDK/pRb and MDM2/P53 pathways. Its aberrant expression has been prevalently found in human hepatocellular carcinomas (HCC) and esophagus squamous cell carcinomas (ESCC), indicative of the potential of gankyrin as a rational diagnostic and therapeutic target in cancers. Here, we review the unique structural features and functional diversity of gankyrin, and discuss its implication in cancer diagnostics and therapeutics from the perspective of chemical biology.

Loading

Article metrics loading...

/content/journals/ccb/10.2174/187231310790226233
2010-01-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/ccb/10.2174/187231310790226233
Loading

  • Article Type:
    Research Article
Keyword(s): cancer; gankyrin; oncoprotein; Structure and function
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test